Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 2:26 AM
Study NCT ID:
NCT07414758
Status:
RECRUITING
Last Update Posted:
2026-02-24
First Post:
2026-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy
Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-09
First Submit QC Date:
None
Study First Post Date:
2026-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-20
Last Update Post Date:
2026-02-24
Last Update Post Date Type:
ACTUAL